Literature DB >> 1168915

Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species (38484).

R Walter, A Neidle, N Marks.   

Abstract

The acyclic C-terminal tripeptide of oxytocin, H-Pro-Leu-Gly-NH-2, is not degraded upon incubation with human (male,female or pregnant female) plasma or serum for 1hr at 37 degrees. However, the sera of other species tested, including rat, chicken and carp, degrade this tripeptide 100%, 4% and 30%, respectively, in 1 hr, as determined by quantitative amino acid analysis of released products. Among the species studied there seems to exist a correlation between the anatomic development of the pars intermedia and the ability of the serum to hydrolyze H-Pro-Leu-Gly-NH-2, which has been proposed to be a MSH-release-inhibiting factor. The only identified degradation products are Pro, Leu and H-Gly-NH-2 with no detectable levels of H-Leu-Gly-NH2. The dipeptides H-Leu-Gly-NH-2 and H-Pro-Leu-OH are each cleaved at similiar rates in either human or rat serum, although the rate of hydrolysis of both peptides is lower in human than in rat. Thus, it does not appear that the dipeptide, H-EU-Gly-NH-2, can accumulate as one of the breakdown products of the tripeptide. The arylamidase present in rat serum has different characteristics from the enzyme in rat brain which can degrade H-Pro-Leu-Gly-NH-2.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168915     DOI: 10.3181/00379727-148-38484

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

2.  Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum.

Authors:  M F Powell; T Stewart; L Otvos; L Urge; F C Gaeta; A Sette; T Arrhenius; D Thomson; K Soda; S M Colon
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

3.  Des-enkephalin-gamma-endorphin (DE gamma E): biotransformation in rat, dog and human plasma.

Authors:  J Coos Verhoef; H M Van den Wildenberg; J W Van Nispen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

4.  Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma.

Authors:  Kuo-Yuan Hung; Renata Kowalczyk; Ami Desai; Margaret A Brimble; John F Marshall; Paul W R Harris
Journal:  Molecules       Date:  2022-07-06       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.